Increased risk for herpetic eye disease in patients with allergic conjunctivitis

Igor Kaiserman; Nadia Kaiserman; Asher Elhayany; Shlomo Vinker

doi:10.1080/02713680600878808

Increased risk for herpetic eye disease in patients with allergic conjunctivitis

Igor Kaiserman, Nadia Kaiserman, Asher Elhayany, Shlomo Vinker

Barzilai University Medical Center

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Purpose: To evaluate the risk of ocular surface herpetic eye disease (osHED) in allergic eye disease. Methods: We calculated the risk for osHED in 11,205 patients on antiallergic ocular topical agents compared with 453,069 controls based on filled prescriptions for topical acyclovir between 2001 and 2003. Results: Significantly more allergic patients, of all age groups, received treatment for osHED (p < 0.01). The age and gender adjusted relative risk for allergic patients to suffer an osHED event was 2.31 (95% CI: 1.84-2.90), raising to 3.55 (95% CI: 2.0-6.4) in patients that filled ≥4 antiallergic prescriptions. Conclusions: Patients treated for allergic eye disease have an increased risk of osHED.

Original language	English
Pages (from-to)	721-725
Number of pages	5
Journal	Current Eye Research
Volume	31
Issue number	9
DOIs	https://doi.org/10.1080/02713680600878808
State	Published - 1 Sep 2006

Keywords

Allergic conjunctivitis
Herpetic eye disease
Prescriptions database

ASJC Scopus subject areas

Ophthalmology
Sensory Systems
Cellular and Molecular Neuroscience

Access to Document

10.1080/02713680600878808

Cite this

@article{0f4715c74f5140cb8adbc7e729c44497,

title = "Increased risk for herpetic eye disease in patients with allergic conjunctivitis",

abstract = "Purpose: To evaluate the risk of ocular surface herpetic eye disease (osHED) in allergic eye disease. Methods: We calculated the risk for osHED in 11,205 patients on antiallergic ocular topical agents compared with 453,069 controls based on filled prescriptions for topical acyclovir between 2001 and 2003. Results: Significantly more allergic patients, of all age groups, received treatment for osHED (p < 0.01). The age and gender adjusted relative risk for allergic patients to suffer an osHED event was 2.31 (95% CI: 1.84-2.90), raising to 3.55 (95% CI: 2.0-6.4) in patients that filled ≥4 antiallergic prescriptions. Conclusions: Patients treated for allergic eye disease have an increased risk of osHED.",

keywords = "Allergic conjunctivitis, Herpetic eye disease, Prescriptions database",

author = "Igor Kaiserman and Nadia Kaiserman and Asher Elhayany and Shlomo Vinker",

year = "2006",

month = sep,

day = "1",

doi = "10.1080/02713680600878808",

language = "English",

volume = "31",

pages = "721--725",

journal = "Current Eye Research",

issn = "0271-3683",

publisher = "Taylor and Francis Ltd.",

number = "9",

}

TY - JOUR

T1 - Increased risk for herpetic eye disease in patients with allergic conjunctivitis

AU - Kaiserman, Igor

AU - Kaiserman, Nadia

AU - Elhayany, Asher

AU - Vinker, Shlomo

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Purpose: To evaluate the risk of ocular surface herpetic eye disease (osHED) in allergic eye disease. Methods: We calculated the risk for osHED in 11,205 patients on antiallergic ocular topical agents compared with 453,069 controls based on filled prescriptions for topical acyclovir between 2001 and 2003. Results: Significantly more allergic patients, of all age groups, received treatment for osHED (p < 0.01). The age and gender adjusted relative risk for allergic patients to suffer an osHED event was 2.31 (95% CI: 1.84-2.90), raising to 3.55 (95% CI: 2.0-6.4) in patients that filled ≥4 antiallergic prescriptions. Conclusions: Patients treated for allergic eye disease have an increased risk of osHED.

AB - Purpose: To evaluate the risk of ocular surface herpetic eye disease (osHED) in allergic eye disease. Methods: We calculated the risk for osHED in 11,205 patients on antiallergic ocular topical agents compared with 453,069 controls based on filled prescriptions for topical acyclovir between 2001 and 2003. Results: Significantly more allergic patients, of all age groups, received treatment for osHED (p < 0.01). The age and gender adjusted relative risk for allergic patients to suffer an osHED event was 2.31 (95% CI: 1.84-2.90), raising to 3.55 (95% CI: 2.0-6.4) in patients that filled ≥4 antiallergic prescriptions. Conclusions: Patients treated for allergic eye disease have an increased risk of osHED.

KW - Allergic conjunctivitis

KW - Herpetic eye disease

KW - Prescriptions database

UR - http://www.scopus.com/inward/record.url?scp=33748535086&partnerID=8YFLogxK

U2 - 10.1080/02713680600878808

DO - 10.1080/02713680600878808

M3 - Article

C2 - 16966144

AN - SCOPUS:33748535086

SN - 0271-3683

VL - 31

SP - 721

EP - 725

JO - Current Eye Research

JF - Current Eye Research

IS - 9

ER -

Increased risk for herpetic eye disease in patients with allergic conjunctivitis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this